227 related articles for article (PubMed ID: 32376286)
1. Epigenetic regulation of the ITGB4 gene in prostate cancer.
Wilkinson EJ; Woodworth AM; Parker M; Phillips JL; Malley RC; Dickinson JL; Holloway AF
Exp Cell Res; 2020 Jul; 392(2):112055. PubMed ID: 32376286
[TBL] [Abstract][Full Text] [Related]
2. Regulation of the ITGA2 gene by epigenetic mechanisms in prostate cancer.
Chin SP; Marthick JR; West AC; Short AK; Chuckowree J; Polanowski AM; Thomson RJ; Holloway AF; Dickinson JL
Prostate; 2015 May; 75(7):723-34. PubMed ID: 25662931
[TBL] [Abstract][Full Text] [Related]
3. DNA methylation down-regulates integrin β4 expression in asthmatic airway epithelial cells.
Wu M; Yang Y; Yuan L; Yang M; Wang L; Du X; Qin L; Wu S; Xiang Y; Qu X; Liu H; Qin X; Liu C
Clin Exp Allergy; 2020 Oct; 50(10):1127-1139. PubMed ID: 32618381
[TBL] [Abstract][Full Text] [Related]
4. CpG island promoter methylation and silencing of 14-3-3sigma gene expression in LNCaP and Tramp-C1 prostate cancer cell lines is associated with methyl-CpG-binding protein MBD2.
Pulukuri SM; Rao JS
Oncogene; 2006 Aug; 25(33):4559-72. PubMed ID: 16786000
[TBL] [Abstract][Full Text] [Related]
5. Reciprocal regulation of integrin β4 and KLF4 promotes gliomagenesis through maintaining cancer stem cell traits.
Ma B; Zhang L; Zou Y; He R; Wu Q; Han C; Zhang B
J Exp Clin Cancer Res; 2019 Jan; 38(1):23. PubMed ID: 30658712
[TBL] [Abstract][Full Text] [Related]
6. Promoter CpG-Site Methylation of the KAI1 Metastasis Suppressor Gene Contributes to Its Epigenetic Repression in Prostate Cancer.
Lee J; Lee MS; Jeoung DI; Kim YM; Lee H
Prostate; 2017 Mar; 77(4):350-360. PubMed ID: 27813113
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic regulation of EFEMP1 in prostate cancer: biological relevance and clinical potential.
Almeida M; Costa VL; Costa NR; Ramalho-Carvalho J; Baptista T; Ribeiro FR; Paulo P; Teixeira MR; Oliveira J; Lothe RA; Lind GE; Henrique R; Jerónimo C
J Cell Mol Med; 2014 Nov; 18(11):2287-97. PubMed ID: 25211630
[TBL] [Abstract][Full Text] [Related]
8. Promoter hypermethylation as a novel regulator of ANO1 expression and function in prostate cancer bone metastasis.
Shin Y; Kim S; An W
Sci Rep; 2024 May; 14(1):11595. PubMed ID: 38773164
[TBL] [Abstract][Full Text] [Related]
9. Deep sequencing reveals distinct patterns of DNA methylation in prostate cancer.
Kim JH; Dhanasekaran SM; Prensner JR; Cao X; Robinson D; Kalyana-Sundaram S; Huang C; Shankar S; Jing X; Iyer M; Hu M; Sam L; Grasso C; Maher CA; Palanisamy N; Mehra R; Kominsky HD; Siddiqui J; Yu J; Qin ZS; Chinnaiyan AM
Genome Res; 2011 Jul; 21(7):1028-41. PubMed ID: 21724842
[TBL] [Abstract][Full Text] [Related]
10. CpG methylation at promoter site -140 inactivates TGFbeta2 receptor gene in prostate cancer.
Zhao H; Shiina H; Greene KL; Li LC; Tanaka Y; Kishi H; Igawa M; Kane CJ; Carroll P; Dahiya R
Cancer; 2005 Jul; 104(1):44-52. PubMed ID: 15895377
[TBL] [Abstract][Full Text] [Related]
11. DNA methylation paradigm shift: 15-lipoxygenase-1 upregulation in prostatic intraepithelial neoplasia and prostate cancer by atypical promoter hypermethylation.
Kelavkar UP; Harya NS; Hutzley J; Bacich DJ; Monzon FA; Chandran U; Dhir R; O'Keefe DS
Prostaglandins Other Lipid Mediat; 2007 Jan; 82(1-4):185-97. PubMed ID: 17164146
[TBL] [Abstract][Full Text] [Related]
12. p21WAF1/CIP1 gene is inactivated in metastatic prostatic cancer cell lines by promoter methylation.
Bott SR; Arya M; Kirby RS; Williamson M
Prostate Cancer Prostatic Dis; 2005; 8(4):321-6. PubMed ID: 16276353
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic DNA methylation of antioxidative stress regulator NRF2 in human prostate cancer.
Khor TO; Fuentes F; Shu L; Paredes-Gonzalez X; Yang AY; Liu Y; Smiraglia DJ; Yegnasubramanian S; Nelson WG; Kong AN
Cancer Prev Res (Phila); 2014 Dec; 7(12):1186-97. PubMed ID: 25266896
[TBL] [Abstract][Full Text] [Related]
14. HIC1 modulates prostate cancer progression by epigenetic modification.
Zheng J; Wang J; Sun X; Hao M; Ding T; Xiong D; Wang X; Zhu Y; Xiao G; Cheng G; Zhao M; Zhang J; Wang J
Clin Cancer Res; 2013 Mar; 19(6):1400-10. PubMed ID: 23340301
[TBL] [Abstract][Full Text] [Related]
15. Increased heparanase expression is caused by promoter hypomethylation and up-regulation of transcriptional factor early growth response-1 in human prostate cancer.
Ogishima T; Shiina H; Breault JE; Tabatabai L; Bassett WW; Enokida H; Li LC; Kawakami T; Urakami S; Ribeiro-Filho LA; Terashima M; Fujime M; Igawa M; Dahiya R
Clin Cancer Res; 2005 Feb; 11(3):1028-36. PubMed ID: 15709168
[TBL] [Abstract][Full Text] [Related]
16. Hypermethylation of CpG islands in primary and metastatic human prostate cancer.
Yegnasubramanian S; Kowalski J; Gonzalgo ML; Zahurak M; Piantadosi S; Walsh PC; Bova GS; De Marzo AM; Isaacs WB; Nelson WG
Cancer Res; 2004 Mar; 64(6):1975-86. PubMed ID: 15026333
[TBL] [Abstract][Full Text] [Related]
17. Methylation of Integrin α4 and E-Cadherin Genes in Human Prostate Cancer.
Mostafavi-Pour Z; Kianpour S; Dehghani M; Mokarram P; Torabinejad S; Monabati A
Pathol Oncol Res; 2015 Sep; 21(4):921-7. PubMed ID: 25743258
[TBL] [Abstract][Full Text] [Related]
18. Identification of differentially methylated CpG islands in prostate cancer.
Yamada Y; Toyota M; Hirokawa Y; Suzuki H; Takagi A; Matsuzaki T; Sugimura Y; Yatani R; Shiraishi T; Watanabe M
Int J Cancer; 2004 Dec; 112(5):840-5. PubMed ID: 15386391
[TBL] [Abstract][Full Text] [Related]
19. Epigenetic inactivation of FAT4 contributes to gastric field cancerization.
Yoshida S; Yamashita S; Niwa T; Mori A; Ito S; Ichinose M; Ushijima T
Gastric Cancer; 2017 Jan; 20(1):136-145. PubMed ID: 26792292
[TBL] [Abstract][Full Text] [Related]
20. Identification of CpG Sites of
Hagelgans A; Jandeck C; Friedemann M; Donchin A; Richter S; Menschikowski M
Anticancer Res; 2017 Dec; 37(12):6609-6618. PubMed ID: 29187436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
